New Approvals

FDA Approves Irinotecan Liposome for Metastatic Pancreatic Adenocarcinoma

By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY On February 13, 2024, the U.S. Food and Drug Administration granted approval for the…

2 months ago

FDA approves eflornithine for high-risk neuroblastoma following partial response to prior therapy.

By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY On December 13, 2023, the U.S. Food and Drug Administration granted approval to eflornithine…

4 months ago

FDA Approves Enfortumab and Pembrolizumab for Urothelial Cancer in an advanced or metastatic stage

By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY The U.S. Food and Drug Administration gave its approval for the use of enfortumab…

4 months ago

FDA Approves Belzutifan for Advanced Renal Cell Carcinoma with prior therapy.

By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY On December 14, 2023, the U.S. Food and Drug Administration granted approval to belzutifan…

4 months ago

The U.S. Food and Drug Administration approved Pembrolizumab (Keytruda) plus fluoropyrimidine- and platinum-containing chemotherapy as the first line treatment for adults

By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY On November 16, 2023, the U.S. Food and Drug Administration approved Pembrolizumab (Keytruda) plus…

5 months ago

FDA Approves Nirogacestat for Adult Patients with Progressing Desmoid Tumors

By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY On the date of approval, the U.S. Food and Drug Administration approved Nirogacestat (Ogsiveo)…

5 months ago

Capivasertib Gets FDA Approval for Treatment of HR-Positive, HER2-Negative Breast Cancer

By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY   On November 16, 2023, the U.S. Food and Drug Administration approved capivasertib (Truqap,…

5 months ago

FDA Grants accelerated approval to Pirtobrutinib for Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma with Prior Therapy

By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY The U.S. Food and Drug Administration granted accelerated approval for Pirtobrutinib (Jaypirca) to be…

5 months ago

FDA Approves Fruquintinib for Metastatic Colorectal Cancer with Prior Treatment History

By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY On November 8, 2023, the U.S. Food and Drug Administration granted approval to Fruquintinib…

6 months ago

FDA Approves Toripalimab for Nasopharyngeal Carcinoma

By: Dr. Anish Shah  Bronx-Lebanon Hospital; Bronx, NY On October 27, the U.S. Food and Drug Administration approved toripalimab-tpzi (Loqtorzi) in combination…

6 months ago
Show more Posts